JILLIAN ZEMBOWER: Open Payments
NPI 1700300886 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 4 payments from 4 companies in 2025. Trend: 2023 $143 · 2024 $157 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, MAVYRET, REXULTI.
Industry payments across OH — which companies pay providers there.
